Doctor profile · Federal record
Dr. J. EVANS, M.D.
Endocrinology, Diabetes & Metabolism Physician (CMS: ENDOCRINOLOGY) · Specialist · Internal Medicine Physician · JACKSONVILLE, FL
- NPI 1699779975
- Accepts Medicare
- MIPS 88.8 / 100 · 2023
- 39 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
915 W MONROE ST STE 200
JACKSONVILLE, FL 322041177
(904) 384-2240
fax (904) 486-2314
Credentials & registration
- NPI registered
- June 2005 — 21 yrs on file
- Profile last updated
- February 4, 2025
- Year of graduation
- 1987 — 39 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State license (1)
- Florida #ME63658
- Medicaid
- FL #373062000
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1699779975. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,703
Distinct HCPCS
6
Medicare allowed
$172,667
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 691 | 267 | $125 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 607 | 404 | $89 | |
76536 |
Ultrasound scan of head and neck soft tissue | 202 | 193 | $108 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 147 | 62 | $34 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 38 | 38 | $112 | |
96401 |
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 18 | 17 | $70 |
In context: peer comparison
Among 20 peers in this city , average services per provider: 180. This provider delivers 9.5× the peer median.Open Payments
Industry payments received
All-time total
$2,201
Transactions
87
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbott Laboratories | 27 | $623.84 | |
| Medtronic, Inc. | 9 | $337.27 | |
| Novo Nordisk Inc | 12 | $309.57 | |
| Corcept Therapeutics | 3 | $167.55 | |
| Insulet Corporation | 9 | $144.15 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $108.45 | |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $74.84 | |
| SANOFI-AVENTIS U.S. LLC | 3 | $72.41 | |
| Boston Scientific Corporation | 2 | $60.40 | |
| Alexion Pharmaceuticals, Inc. | 3 | $56.15 | |
| Xeris Pharmaceuticals, Inc. | 2 | $43.32 | |
| Lilly USA, LLC | 2 | $38.35 | |
| Amgen Inc. | 2 | $33.28 | |
| Neurocrine Biosciences, Inc. | 1 | $25.35 | |
| Radius Health, Inc. | 1 | $21.07 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,617
Patients
695
Total drug cost
$1,224,014
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Levothyroxine Sodium | Generic | 690 | 178 | $11,060 |
| Synthroid (Levothyroxine Sodium) | Brand | 335 | 71 | $33,289 |
| Atorvastatin Calcium | Generic | 201 | 63 | $2,767 |
| Januvia (Sitagliptin Phosphate) | Brand | 196 | 36 | $186,770 |
| Metformin Hcl | Generic | 187 | 53 | $1,186 |
| Jardiance (Empagliflozin) | Brand | 186 | 31 | $186,608 |
| Novolog Flexpen (Insulin Aspart) | Brand | 135 | 41 | $194,260 |
| Lantus Solostar (Insulin Glargine,hum.Rec.Anlog) | Brand | 130 | 44 | $117,198 |
| Ozempic (Semaglutide) | Brand | 108 | 28 | $159,817 |
| Trulicity (Dulaglutide) | Brand | 96 | 21 | $132,743 |